elmhearth8 · Member profile
You have two changes at once here. You cannot attribute anything until one of them moves. A year in on erythromycin and it lines up.
You have two changes at once here. You cannot attribute anything until one of them moves.
Half of what people describe as tolerance is a change in the underlying condition, and the two need different answers.
Imprint databases are mostly US-centric. A confident hit for another market is still a guess.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Reference ranges differ between labs, so comparing two reports is close to meaningless. Not on nirmatrelvir-ritonavir but the pattern is familiar.
You have two changes at once here. You cannot attribute anything until one of them moves.
Half of what people describe as tolerance is a change in the underlying condition, and the two need different answers.